Valder R. Arruda
9Patents
1h-index
7Co-inventors
44Inventor score
Filing activity: Jun 8, 2000 → Oct 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10442850B2 | Compositions and methods for enhancing coagulation factor VIII function | Human Necessities | 2 | Active |
| US9670267B2 | Compositions and methods for enhancing coagulation factor VIII function | Human Necessities | 1 | Active |
| US8063022B1 | Methods for preventing formation of inhibitory antibodies in the setting of gene therapy | Human Necessities | 1 | Expired |
| US8816054B2 | Compositions and methods for enhancing coagulation Factor VIII function | Human Necessities | 1 | Active |
| US12252528B2 | Compositions and methods for modulating Factor VIII function | Human Necessities | 0 | Active |
| US8236764B2 | Methods for treating a hemostasis related disorder using activated forms of Factor V | Chemistry; Metallurgy | 0 | Active |
| US10676731B2 | Compositions and methods for modulating factor IX function | Human Necessities | 0 | Active |
| US8470557B2 | Isolated nucleic acids encoding activated factor V and methods for production thereof | Chemistry; Metallurgy | 0 | Active |
| US11708570B2 | Compositions and methods for modulating Factor IX function | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.